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Abstract
High-intensity intermittent training (HIIT) has been shown to reduce the risk of
chronic conditions including the development of type 2 diabetes mellitus
(T2DM). Independently, a low vitamin D status has also been linked to the
prevalence of T2DM. The aim of this study was to investigate if there was a syn-
ergistic metabolic effect of HIIT and vitamin D supplementation on glycemic
control. A total of 20 male and female participants (age, 34  9 year; BMI,
31.4  2.8 kgm2) completed 6 weeks HIIT, and were randomized to ingest
100 lgday-1 of vitamin D3 or placebo. Response to an oral glucose tolerance test
(OGTT) was determined at baseline and at 72 h postintervention. Glucose toler-
ance was improved as a result of the HIIT intervention, shown through a reduc-
tion in glucose and insulin concentrations during the OGTT, accompanied by a
decrease in glucose (829  110 to 786  139 mmolh1L1; P = 0.043) and
insulin (8101  4755–7024  4489 mUh1L1; P = 0.049) area under the
curve (AUC). Supplementation increased 25-hydroxyvitamin D3 concentration
by 120% to a sufficiency status (P < 0.001). However, the consumption of vita-
min D3 seemed to attenuate the glucose response during an OGTT. Triglyceride
content was lowered following the intervention (P = 0.025). There was no effect
of the intervention on insulin sensitivity (IS) indices: ISIMatsuda and HOMA-IR.
Our findings demonstrate that HIIT improves glucose tolerance in nondiabetic
overweight and obese adults; however vitamin D3 supplementation did not prof-
fer any additional positive effects on the measured indices of metabolic health.
Introduction
Obesity and lack of regular exercise are reported to be the
leading causes of chronic diseases (Booth et al. 2012) and
global mortality (WHO, 2010), with exercise playing a
major role in the prevention of type 2 diabetes mellitus
(T2DM) (Pan et al. 1997; Boule et al. 2001; Knowler
et al. 2002). The initial pathophysiological events in the
development of T2DM are insulin resistance, glucose
intolerance, and chronic hyperglycemia (Kahn 2003), sug-
gesting interventions should address these underpinning
metabolic syndromes. High-intensity intermittent training
(HIIT) and sprint interval training (SIT), involving
repeated short bouts of high-intensity exercise (above
85% of maximal aerobic capacity), have been reported to
improve insulin sensitivity (IS) (Babraj et al. 2009) and
glucose tolerance (Little et al. 2011, 2014).
In addition to the low exercise status in the UK
(BHF, 2015), another contributor in the etiology of
chronic diseases, such as T2DM, multiple sclerosis, and
cardiovascular disease, is vitamin D deficiency (Holick
2004). The high northern latitude of the UK (50°–59°N)
and the prevailing cloud cover and poor weather condi-
tions does not facilitate sufficient vitamin D skin synthe-
sis to increase or maintain a sufficient vitamin D status
(Rhodes et al. 2010), and thus renders much of the
nation vitamin D deficiency (Hypponen and Power
2007; Zgaga et al. 2011). The systemic concentration of
25-hydroxyvitamin D3 (25[OH]D3) defines vitamin D
status, with deficiency classified as a concentration of
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<20 ngmL1 and sufficiency as > 30 ngmL1 (Holick
et al. 2011).
A low vitamin D status is often associated with meta-
bolic disruptions, one of which is an increased risk of glu-
cose intolerance (Chiu et al. 2004), with reports that
obesity is inversely correlated with vitamin D status, attri-
butable to the sequestering of fat-soluble 25(OH)D by
adipocytes (Wortsman et al. 2000). The inverse associa-
tion reported between obesity and maintaining eug-
lycemia, suggests that excess fat mass is a risk factor in
the etiology of the disease (Must et al. 1999). However,
there is conflicting evidence surrounding the efficacy of
vitamin D3 supplementation alone to improve glucose
tolerance, and little research investigating a combined
effect of vitamin D3 supplementation and exercise
training.
A recent study reported vitamin D insufficiency to be
linked to reduced glucose tolerance compared to individ-
uals with a sufficient status (Kobza et al. 2013). However,
the effect of baseline vitamin D status was independent of
the effect of resistance training on improvements in glu-
cose tolerance. However, supplementation with vitamin
D3 has been demonstrated to increase vitamin D concen-
tration (Barker et al. 2013) and expression of the key
receptor that mediates the transcriptional action of vita-
min D, the vitamin D receptor (VDR), effectively (Ceglia
et al. 2013). It has recently been reported that vitamin D
supplementation alone as an intervention may not
improve insulin sensitivity or glycemic control in an over-
weight and obese population (Mousa et al. 2017).
Research suggests that the active vitamin D metabolite,
1,25(OH)2D3, acts directly through the VDR to stimulate
insulin biosynthesis or suppression (Maestro et al. 2000,
2002; Tiosano et al. 2001), therefore suggesting scope for
vitamin D to influence glycemic control through insulin
bioavailability. Studies have also shown that mechanical
stress, in the form of exercise, that is HIIT, can alter the
expression and action of 1,25(OH)2D3 and the VDR
(Makanae et al. 2015; Aly et al. 2016). This may create an
interlinking pathway between exercise-induced metabolic
and cellular alterations and cellular vitamin D metabo-
lism, in order to influence glucose tolerance. The purpose
of this investigation was to examine the combined effects
of exercise in for the form of HIIT and vitamin D3 sup-
plementation on glycemic control in an overweight and
obese adult population.
Materials and Methods
Ethical approval
The study was approved by the School of Applied Sciences
Research Integrity Approvals Group at Edinburgh Napier
University in July 2014 (reference number: FHLSS/1000).
The study and procedures conformed to the standards set
by the latest version of the Declaration of Helsinki or the
version that was in place at the time of the experiments.
Informed written and verbal consent was obtained from all
participants.
Participants
A total of 22 overweight and obese Caucasian males
(n = 15) and females (n = 7) were recruited to participate
in the study (age 19–45 year). All of the volunteers had a
body mass index (BMI) between 27 and 35 kgm2 but
were otherwise healthy and did not engage in more than
two bouts of light to moderate intensity exercise per
week. Participants were excluded if they were a smoker,
used tanning beds, took supplements containing vitamin
D, or were routinely taking anti-inflammatory drugs, sta-
tins, or steroids. Data collection and sampling took place
over months from October to June to account for sea-
sonal variation in vitamin D status in northern latitudes
(Close et al. 2013).
Baseline testing
The first visit to the laboratory involved basic anthropo-
metric measurements, a maximal exercise test and famil-
iarization to the HIIT protocol. Height, body mass, waist
and hip circumference, and supine blood pressure mea-
surements were taken at baseline. Participants performed
a peak oxygen uptake (V˙O2peak) test that involved a step
increase of 25 W every 2 min on a stationary cycle
ergometer (Velotron Pro, Racer Mate, USA), maintaining
a pedaling cadence of 70 rpm until volitional exhaustion
(Yoon et al. 2007). Expired air was continuously analyzed
via an on-line breath-by-breath gas analysis system (Cor-
tex, MetaLyzer 3B, Germany), and heart rate (HR) was
monitored throughout the test by a chest worn HR moni-
tor (Polar, RS400, Finland). The test was terminated
when the participant could not maintain a pedaling
cadence of >55 rpm. Verbal encouragement was given
throughout the test. The value used for V˙O2peak corre-
sponded to the highest value averaged over 30 sec during
the test. Following a 30-min rest, participants performed
a familiarization trial of the HIIT protocol consisting of
five 1 min intervals (see Training).
Five days after the first session, participants returned to
the laboratory between 0700 and 0900 following a 10-h
overnight fast to complete a standard 75 g oral glucose
tolerance test (OGTT) (WHO, 1980). Participants
refrained from strenuous physical activity the day prior to
the OGTT, and completed a 24-h food diary, which they
were asked to replicate in the day prior to the
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postintervention OGTT. A fasted blood sample was col-
lected into K3 ethylenediaminetetraacetic acid (EDTA)
(approximately 1.0 mg) and sodium fluoride/potassium
oxalate vacutainers via a cannula inserted into the antecu-
bital vein, then participants consumed 75 g glucose dis-
solved in 290 mL of water and 10 mL of lemon juice
over a 5-min period. Further blood samples were subse-
quently taken via the indwelling cannula every 30 min for
a period of 2 h. The cannula was kept patent via regular
flushing with 0.9% saline solution. Participants were
required to remain in a seated position for the 2-h per-
iod. Whole blood was centrifuged (Satorius Universal,
320R, Germany) within 30 min of collection at 1500 g for
15 min at 4°C, and the resulting plasma aliquoted into
Eppendorfs and stored at 80°C for subsequent analysis.
Training
The 6-week supervised HIIT intervention was initiated
within 1–3 days following the OGTT, and consisted of
3 sessions/week in the laboratory separated by 1–2 days.
All sessions were performed on the same stationary cycle
ergometer (Velotron Pro) as the V˙O2peak test, starting
with a 5-min warm up and ending with a 5-min cool
down at a power output of 50 W. The protocol was mod-
eled on recent studies (Little et al. 2011, 2014; Mancilla
et al. 2014) consisting of 10 repetitions of 1 min intervals
interspersed with 1 min active recovery at a power output
of 50 W. The power output (W) of the high-intensity
intervals was assigned as a workload corresponding to
100% V˙O2peak (sessions 1–6) to 110% (sessions 7–12),
and ultimately 120% (sessions 13–18). Heart rate and rate
of perceived exertion (RPE) (Borg 1998) were monitored
throughout each session.
Supplementation
Participants were randomized (1:1) to receive a 6-week
course of vitamin D3 supplements or placebo tablets (Pla-
cebo-World, Powys, UK). The vitamin D3 supplement
capsules (Solgar, New Jersey) contained a dose of 100 lg
(4000 IU) vitamin D3: the recommended upper intake
limit set by the Institute of Medicine (IOM) (Ross et al.
2011). Distribution of the supplement and placebo
remained blind to both the researcher and participants.
The laboratory technicians distributed the supplements/
tablets in Manilla envelopes and kept a record. Partici-
pants were asked to consume one tablet daily with break-
fast each morning.
All baseline testing were repeated approximately 72 h
after the last training session, with participants arriving to
the lab following a 10-h fast between 0700 and 0830, to
ensure the postintervention OGTT was performed at the
same time of the day as the preintervention OGTT. The
session included the anthropometric measures, OGTT
and V˙O2peak test (following a 30-min rest after the OGTT
was completed).
Blood sample analysis
All assays and analysis methods were performed in dupli-
cate. Whole blood was analyzed for full blood cell count
in vacutainers containing K3 EDTA using a hematology
analyzer (Sysmex, XS 1000i). Plasma samples were
thawed prior to analysis. Commercially available enzyme-
linked immunosorbent assay (ELISA) kits were used to
determine plasma insulin (Mercodia, Uppsala, Sweden),
25(OH)D3 (IDS PLC, Tyne and Wear, UK), adiponectin
(R&D Systems, Minneapolis, MN), and leptin concentra-
tions (R&D Systems, Minneapolis, MN). Plasma glucose,
total cholesterol, triglyceride, and high-density lipid
(HDL) cholesterol concentrations were analyzed using a
bench top clinical chemistry analyzer (Randox, RX Mon-
za, UK). Low-density lipid (LDL) cholesterol concentra-
tion was estimated using the following equation: LDL
cholesterol = Total cholesterol–(triglycerides/2.2)–HDL
cholesterol (Friedewald et al. 1972). Insulin sensitivity
and insulin resistance were calculated using the IS index
(ISIMatsuda) proposed by Matsuda and DeFronzo (Mat-
suda and DeFronzo 1999), and the homeostatic model
assessment of insulin resistance (HOMA-IR) (Matthews
et al. 1985).
Statistical analysis
Data are presented as means  SD. All statistical tests
were performed using SPSS 23.0 statistical software (IBM
Analytics, New York). Significance was accepted at
P < 0.05. Data were checked for normal distribution
using the Shapiro–Wilk test. The baseline participant
characteristics were checked for statistical difference
between the two groups: placebo and vitamin D supple-
ment group using independent samples t-tests. All data,
except the OGTT insulin data, are normally distributed
and parametric tests were performed. The OGTT insulin
data were log transformed prior to statistical analysis. A
two-way repeated measures analysis of variance (ANOVA)
was used to analyze the systemic insulin and glucose
response to the OGTT, separately, determining the main
effect of time (pre- to postintervention OGTT trials), and
condition (vitamin D3 supplementation and placebo)-by-
time interactions. The dependent variable was condition,
and the independent variable was glucose or insulin con-
centration across the five time points (0, 30, 60, 90, and
120 min) during the OGTT’s (repeated measures) from
pre- to postintervention.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
2018 | Vol. 6 | Iss. 9 | e13684
Page 3
H. M. Lithgow et al. Effect of HIIT and Vitamin D on Glycemic Control
A two-way (2 9 2) ANOVA was used to determine the
main effect of time (pre- to postintervention), and condi-
tion (vitamin D3 supplementation and placebo)-by-time
interactions for all measured dependent variables pre-
and postintervention: vitamin D concentration, adiponec-
tin concentration, Leptin concentration, cholesterol
concentration, triglyceride concentration, HDL and LDL
cholesterol concentrations, fasting plasma glucose and
insulin concentrations, ISmatsuda, and HOMA-IR.
Results
Twenty participants completed the study, with two partic-
ipants withdrawing due to alternative time commitments.
Adherence to supplement and placebo consumption was
self-reported by participants and was reported as 100%
compliance. Adherence to the HIIT sessions was reported
as 99.4% compliance.
Anthropometric and performance
measurements
Baseline characteristics and postintervention measures of
all participants (n = 20), the vitamin D (n = 10) group
and the placebo group (n = 10), are shown in Table 1.
There were no significant differences between groups at
baseline. Both waist and hip circumference were reduced
(P = 0.019; P = 0.002, respectively) as a result of the
HIIT program; this was accompanied by a decline in the
systolic blood pressure by 6 mmHg after the 6 weeks
(P = 0.004); however, there was no influence of vitamin
D supplementation on these outcomes (Table 1). V˙O2peak
was increased after 6 weeks of HIIT in both absolute
terms and relative to body mass by 12% (P < 0.001).
Similarly, absolute and relative peak power output
increased from pre- to postintervention by 17%
(P < 0.001). Vitamin D supplementation did not influ-
ence the performance outcomes.
Vitamin D concentration
There was an overall effect of the intervention on plasma
25(OH)D3 concentration (P < 0.001; Figure 1), with a
clear effect of vitamin D supplementation, whereby the
plasma 25(OH)D3 concentration of the vitamin D supple-
mented group increased from 14.4  4.6 ngmL1 at
baseline to 29.7  6.9 ngmL1 (P < 0.001). The placebo
group exhibited no change in plasma 25(OH)D3
concentration (12.5  4.0–13.6  5.7 ngmL1) showing
the comparative effect of a lack of vitamin D
supplementation.
Insulin sensitivity and OGTT outcomes
Glucose tolerance was improved through the reduction in
circulating plasma glucose concentrations (P = 0.027,
Fig. 2A) and insulin concentrations (P = 0.017, Fig. 2B)
during the 120-min OGTT performed at baseline and
postintervention, with an effect of supplementation on
the response (P = 0.038). There was a reduction in both
glucose AUC (P = 0.043) and insulin AUC (P = 0.049) as
an overall effect of the intervention, with an effect of sup-
plementation observed on glucose AUC (P = 0.035)
whereby vitamin D supplementation attenuated the
improvement in glucose AUC (Table 2). Insulin sensitiv-
ity did not change significantly from pre- to postinterven-
tion, as assessed by ISIMatsuda (P = 0.087) and HOMA-IR
(P = 0.676).
Other metabolic markers
There was a decrease in adiponectin concentration as a
result of the 6-week intervention (P = 0.004); however,
there was no effect of supplementation observed (Table 2).
There were no differences observed in leptin concentration
in response to the intervention (Table 2). Circulating
triglyceride content was lowered as a result of the interven-
tion, with a main effect of time observed (P = 0.025),
although there was no effect of supplementation on triglyc-
eride levels (P = 0.443; Table 2). No differences were
observed from pre- to postintervention for total choles-
terol, HDL or LDL cholesterol (Table 2), or any of the
hematological parameters that were measured (Table 3).
Discussion
In the present study, the findings indicate that 6 weeks of
HIIT improves glucose tolerance, shown through a reduc-
tion in systemic glucose concentration and the concentra-
tion of insulin required to mediate euglycemia (AUC
data). There appears to be an attenuation of the HIIT-
induced improvement in glucose AUC with vitamin D
supplementation. Contrary to the hypothesis, the absence
of vitamin D3 supplementation induced a greater reduc-
tion in circulating glucose concentration during the
OGTT compared to vitamin D consumption, which suc-
cessfully elevated vitamin D status to sufficiency
(>30 ngmL1). The intervention did not affect indices of
IS (ISIMatsuda and HOMA-IR); however, this may be
attributed to the relatively small sample size, underpow-
ered, and the interindividual variability in the insulin
data. The HIIT protocol adopted in the current investiga-
tion and previously used in other studies (Little et al.
2011, 2014; Mancilla et al. 2014) was effective at
2018 | Vol. 6 | Iss. 9 | e13684
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improving aerobic capacity and physical performance,
while other HIIT-induced significant physiological find-
ings were a reduction in adiponectin concentration and
triglyceride content.
Glycemic control is an important metabolic aspect in the
prevention of T2DM and is identified as a risk factor in the
development of diabetic complications (Woerle et al.
2007). Although no change was found in the ISIMatsuda or
HOMA-IR, there was a reduction in postprandial glucose
concentration accompanied by a decrease in plasma insulin
concentration, suggesting systemic glycemic regulation is
improved. Similar to our results, improvements in glycemic
control have been reported in overweight and obese adults
after just 2 weeks (6 sessions) of HIIT (Whyte et al. 2010),
with 12 weeks inducing considerable reductions in insulin
resistance in overweight adults with T2DM (Mitranun
et al. 2014) and without T2DM (Racil et al. 2013). The lat-
ter studies differ to our current investigation in that the
HIIT program involved either shorter (30 sec) maximal
sprints (Whyte et al. 2010; Racil et al. 2013) or the training
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Figure 1. Plasma 25(OH)D3 concentrations at baseline and
postintervention for the placebo group and the vitamin D group.
*Denotes a significant condition (vitamin D supplement vs.
placebo)-by-time (pre to post) interaction effect; P < 0.05.
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induced a reduction in BMI (Mitranun et al. 2014).
Although in the current study the authors observed a
decrease in waist and hip circumference, and thus, a benefi-
cial change in body fat distribution or body composition,
there was no observed change in body mass. It should also
be considered that diet was not controlled or monitored
during the 6 weeks intervention, although participants
were requested to maintain their habitual diet and activity.
Furthermore, fasting plasma insulin and glucose
remained unchanged; therefore, a change in HOMA-IR
may be unlikely despite a change in mean plasma glucose
and insulin concentration during the OGTT. However,
ISIMatsuda is calculated from both fasting values and
changing values during the OGTT; therefore should be
possible to detect changes in IS, however a greater sample
size may be required. Although, a HIIT-induced reduc-
tion in HOMA-IR was observed following 6 weeks of a
similar exercise protocol, and was retained after 3 weeks
cessation of training (Phillips et al. 2017). The current
study population was nondiabetic and had normal fasting
glucose and insulin concentrations; therefore, the intent
of the intervention was not to alter fasting values but to
improve glucose tolerance and thus reduce the require-
ment of insulin to control systemic glucose.
An interesting finding of the study was an attenuation
of the HIIT-induced improvement in glucose concentra-
tion during the OGTT, improving the body’s euglyce-
mic environment. This was contrary to the hypothesis,
and may be attributed to the interindividual variability
measured during glucose tolerance tests combined with
small sample sizes, as reported in the HERITAGE Family
Study (Boule et al. 2005). The inconsistent response by
individual participants has also been reported by small
training studies utilizing the same protocol but reporting
different effects on insulin sensitivity (Metcalfe et al.
2012, 2016).
The timing of the postintervention blood sampling
should be considered. Methodology differs between stud-
ies with regard to analysis of IS: OGTT or the gold stan-
dard hyperinsulinemic euglycemic clamp, as does timing
of the test: 15–72 h posttraining. In the current study, the
postintervention OGTT was performed 72 h after the ces-
sation of the intervention to prevent any residual effects
of the last HIIT session on blood markers. Studies that
performed the OGTT 24 h after the final HIIT bout may
reflect the combined impact of acute and chronic exercise
training (Rogers 1989). The difference between the
response to a 75 g OGTT at 24 h and 72 h post-2 weeks
of training has been demonstrated by Whyte et al. (2010),
whereby they reported an increase in the
ISIMatsuda after 24 h but the impact was lost at 72 h.
Therefore, the lack of effect on ISIMatsuda and HOMA-IR
in the current study at 72 h postintervention could be
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attributed to the loss of the acute molecular response.
However, an increase in IS expressed by the Cederholm
Index, has been reported (in men only) at the 72 h time
point following a 6-week HIIT intervention (Metcalfe
et al. 2012). Although, the Cederholm Index is not as
commonly reported in epidemiological studies as the
Matsuda Index, as the correlation coefficient with the
gold standard hyperinsulinemic-euglycemic clamp (HEC)
is relatively lower (Piche et al. 2007), and therefore is not
as reliable a measure to estimate IS.
Our findings revealed that 17 out of the 20 participants
were classified as vitamin D deficient (<20 ngmL1) at
baseline; however, the remaining 3 participants had con-
centrations of 20.6, 21.0, and 21.2 ngmL1 and thus were
only marginally classified as insufficient. The findings
support the current reports of widespread vitamin D defi-
ciency in the UK (Hypponen and Power 2007; Zgaga
et al. 2011), linked to low ultraviolet (UV) exposure
(Kelly et al. 2015) and that supplementation (with 100 lg
25(OH)D3) can raise vitamin D3 concentration to a suffi-
cient status (>30 ngmL1). Studies investigating the
effects of 25(OH)D3 supplementation have utilized a
range of daily and weekly doses. The relatively high dose
used in the current study was selected based on the sus-
ceptibility of overweight adults in Scotland to be generally
vitamin D deficient (Bolland et al. 2007).
It has been established that a dose-dependent relation-
ship exists for vitamin D3 supplementation (Gallagher et al.
2012; Ekwaru et al. 2014), with baseline concentration
influencing the response to supplementation. The current
study observed relatively low baseline 25(OH)D3 concen-
trations and thus the concentrations postintervention were
not elevated to the same extent as studies prescribing higher
doses for shorter periods. Therefore, it may be that an
increase in 25(OH)D3 alone is less relevant than the abso-
lute concentration, with metabolic benefits attributed to a
high sufficiency status. It is possible that no additional ben-
efit of vitamin D3 supplementation in conjunction with the
HIIT program was observed as participants were deficient
or insufficient for the majority of the 6-week intervention,
due to a 4- to 6-week lag time with supplementation before
normalization of systemic 25(OH)D3 concentrations (Vieth
1999). Future studies investigating the combined effect of
vitamin D and exercise training should supplement partici-
pants prior to commencement of the training intervention,
to address this confounding factor.
Two key hormones expressed in human adipose cells,
adiponectin and leptin, are reported to be linked to glu-
cose regulation (Lihn et al. 2005), with both HIIT and
vitamin D3 supplementation independently shown to
influence concentrations of the proteins (Trapp et al.
2008; Leggate et al. 2012; Belenchia et al. 2013; Breslavsky
et al. 2013; Racil et al. 2013; Ghavamzadeh et al. 2014).
Adiponectin has been suggested to favor the uptake of
glucose into skeletal muscle and thus is regarded as a pre-
dictor for reducing hyperglycemia (Punthakee et al.
2006). Therefore, it would appear that higher circulating
adiponectin would be favorable, which has independently
been reported following 12 weeks HIIT (Racil et al. 2013)
and 12 months vitamin D3 supplementation (Breslavsky
et al. 2013). In contrast to these reports, and in line with
our result, adiponectin has been reported to decrease fol-
lowing HIIT (Leggate et al. 2012), and after a course of
vitamin D3 supplementation (Belenchia et al. 2013). Since
adiponectin is an adipose tissue derived protein hormone,
it has been suggested that fat mass variations override the
effect of exercise on systemic adiponectin (Christiansen
et al. 2010; Gastebois et al. 2016), and thus, the observed
decrease in adiponectin may be due to the reduction in
waist and hip circumference. Furthermore, exercise train-
ing alone can reverse adiponectin resistance at the skeletal
muscle level, thereby reducing the requirement for
bioavailable adiponectin (Van Berendoncks et al. 2010,
2011). Additionally, leptin is often associated with adipo-
nectin, with an elevation in the adiponectin-to-leptin
ratio reported to correlate with a rise in fasting glucose
(Finucane et al. 2009). Changes in leptin have however
been attributed to alterations in body mass, although this
was not observed in the current study. Similarly, alter-
ations in the lipid profile have been associated with
improvements in fat metabolism and body mass (Racil
et al. 2013), which may supersede the effect of HIIT on
fat metabolism.
Conclusions
To our knowledge, no prior study has investigated the
combined effects of HIIT and vitamin D3 supplementa-
tion on physical and metabolic parameters that influence
glycemic control. The key finding of the current study is
that 6 weeks of regular HIIT (3 sessions/week) improved
glucose tolerance in a nondiabetic overweight and obese
population, accompanied by a reduction in adiponectin
concentration and systemic triglyceride content. Vitamin
D3 supplementation increased circulating 25(OH)D3 con-
centration to a sufficient status; however, it unexpectedly
attenuated the HIIT-induced improvement in glucose
AUC. Further studies are required to investigate the
mechanisms involved in altering glucose tolerance and IS
following chronic adaptations to HIIT.
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